Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Accessibility and Personalization of Cognitive Remediation for Schizophrenia

NCT03576976 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03576976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Accessibility and Personalization of Cognitive Remediation for Schizophrenia
Lead sponsor
New York State Psychiatric Institute
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2018
Completion date
May 30, 2022
Enrollment
67 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia